OHI · Intrinsic value
Is Omega Healthcare Investors, Inc. (OHI) overvalued or undervalued?
Omega Healthcare Investors, Inc. (OHI) trades at the delayed market price of $44.90 a share. That price already implies revenue growth of 14.6% a year for 5 years. TickerWorth's dcf fair value is $25.23 a share (78% above fair value), as of Oct 19, 2026. It is a model estimate, and every input behind it is sourced below.
Model by Miraaj Patel · generated from SEC filings and market data · Updated Oct 19, 2026 · How these pages are made
Is OHI overvalued?
- DCF fair value
- $25.23
- Market price
- $44.90
- Downside to fair value
- 43.8%
- Verdict
- 78% above fair value
Reverse DCF: Today's price implies revenue growth of 14.6% a year for 5 years; our model assumes 5.1% a year on average over the same horizon.
What is OHI's TickerWorth Score?
Scores higher than almost every company we compare it with
Compared with Real Estate companies in US
Its strongest point: a profitable, high-quality business.
- Value · 53 of 100
Cheaper than 53% of Real Estate companies in US
- Price vs worth · — of 100
- Quality · 93 of 100
More profitable than 93% of Real Estate companies in US
- Financial health · 53 of 100
Financially stronger than 53% of Real Estate companies in US
- Growth · 63 of 100
Growing faster than 63% of Real Estate companies in US
- Momentum · 54 of 100
Outperformed 54% of Real Estate companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
OHI DCF valuation: what the price assumes
At a recent price of $44.90, Omega Healthcare Investors, Inc. (OHI) trades 78% above TickerWorth's base-case discounted-cash-flow (DCF) fair value of $25.23 per share — meaning the market currently prices OHI overvalued vs our estimate of what the business is intrinsically worth. Our fair value sits below the market, an implied -43.8% move to close the gap if the business performs in line with our assumptions. This is an educational model, not a price target or a recommendation — the value moves with the inputs, which you can test yourself using the WACC slider below.
Read the full reasoning
The valuation discounts Omega Healthcare Investors, Inc.'s projected free cash flows at a weighted-average cost of capital (WACC) of 7.2%, with a long-run terminal growth rate of 2.5%. About 82% of the enterprise value comes from the terminal value — the portion beyond the explicit forecast window — which is typical for a stable, cash-generative business and a reminder that small changes in the discount rate or terminal growth assumption swing the intrinsic value meaningfully.
Running the DCF in reverse — solving for the growth the current price already assumes — the market is implying roughly 14.6% annual revenue growth for OHI. Our base case instead compounds to about 5.1% a year over the same forecast, so the market is pricing in materially faster growth than our base case. The reverse-DCF is a quick sanity check: it reframes 'is this stock cheap?' as 'do I believe the growth the price requires?' rather than arguing over a single point estimate of fair value.
Sensitivity matters more than any single number. Across a reasonable band of discount-rate assumptions, OHI's modeled DCF value ranges from about $12.24 to $67.88 per share. If that range still sits below today's price, the market is optimistic relative to the model across the whole band; if it brackets the price, the stock is roughly fairly valued on our assumptions. Use the interactive slider to see exactly where your own cost-of-capital view lands.
How to read this page: the DCF fair value is what Omega Healthcare Investors, Inc. would be worth if its cash flows grow as modeled and are discounted at the stated WACC. The assumptions table shows every input and its source; the reverse-DCF shows what the market believes; the sensitivity band shows how fragile the answer is. None of this is investment advice — it is a transparent, auditable framework for forming your own view of OHI's intrinsic value. Figures update as new filings and prices come in.
Every input behind OHI's DCF
| Input | Value |
|---|---|
| Base-year revenueOMEGA HEALTHCARE INVESTORS, INC. FY2025 10-K (accession 0000888491-26-000008): us-gaap:Revenues, FY2025 full year. | $1,190,100,000 |
| Base EBIT marginOMEGA HEALTHCARE INVESTORS, INC. FY2019 10-K (accession 0000888491-20-000007): us-gaap:OperatingIncomeLoss 551,745,000 / revenue 1,190,099,000 = 46.36%, FY2025. | 46.4% |
| Forecast revenue growthESTIMATEAssumption — TickerWorth's 5-year explicit forecast | 6% → 6% → 5% → 5% → 4% |
| Risk-free rateLive feed — US 10-year Treasury yield (^TNX) | 5.1% |
| BetaLive feed — yfinance, 5-year monthly beta vs the S&P 500 (clamped to 0.4–2.5) | 0.53 |
| Terminal growthESTIMATEAssumption — TickerWorth house default 2.5%, held below WACC | 2.5% |
| Diluted sharesOMEGA HEALTHCARE INVESTORS, INC. FY2025 10-K (accession 0000888491-26-000008): WeightedAverageNumberOfDilutedSharesOutstanding = 304,952,000 shares, FY2025. | 305M |
| Market priceDelayed quote · as of 2026-10-19 20:14 UTC | $44.90 |
Change OHI's assumptions
The discount-rate dial and the editable model
ProChange growth, margin and WACC yourself — Pro (7-day free trial, card required).
What does Omega Healthcare Investors, Inc. do?
What does it do?
Omega Healthcare Investors, Inc. is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. It operates in the REIT - Healthcare Facilities industry (Real Estate sector), headquartered in United States. The company employs roughly 69 people.
How does it make money?
The business turns $1.2B in annual revenue into profit. Out of every $100 of sales, about $61 is left as operating profit (operating margin of 61.5%), after a 98% gross margin on the products/services it sells. After all costs, taxes and interest, 68.1% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks stretched: carries modest debt (0.7× equity), may struggle to cover its short-term bills (0.4× current ratio), and is currently profitable.
Who at OHI filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Golem Lucas M. | CHIEF ACCOUNTING OFFICER | Grant / award | $2,519.68 | Form 4 for Golem Lucas M. (opens sec.gov in a new tab) | |
| Golem Lucas M. | CHIEF ACCOUNTING OFFICER | Disposition to issuer | $138.93 | Form 4 for Golem Lucas M. (opens sec.gov in a new tab) | |
| Egbuonu-Davis Lisa | Director | Gift | — | Form 4 for Egbuonu-Davis Lisa (opens sec.gov in a new tab) | |
| Ballew Neal | CHIEF ACCOUNTING OFFICER | Grant / award | $6,258.00 | Form 4 for Ballew Neal (opens sec.gov in a new tab) | |
| Ballew Neal | CHIEF ACCOUNTING OFFICER | Disposition to issuer | $524.48 | Form 4 for Ballew Neal (opens sec.gov in a new tab) | |
| WHITMAN BURKE W | Director | Grant / award | $164,985.26 | Form 4 for WHITMAN BURKE W (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Common questions
What is OHI's intrinsic value?
TickerWorth's base-case DCF fair value for Omega Healthcare Investors, Inc. (OHI) is $25.23 per share, versus a market price of $44.90 (78% above fair value).
Is OHI overvalued or undervalued?
On our DCF model OHI looks overvalued vs fair value at $44.90. This is an educational estimate, not advice.
What discount rate is used for OHI?
A WACC of 7.2% and a terminal growth rate of 2.5%.
Is Omega Healthcare Investors stock undervalued?
TickerWorth's dcf fair value for Omega Healthcare Investors, Inc. (OHI) is $25.23 against a market price of $44.90. Our read: 78% above fair value. This is a model estimate, not investment advice.
Omega Healthcare Investors (OHI) DCF valuation and fair value
Our dcf fair value for Omega Healthcare Investors, Inc. (OHI) is $25.23, built on a 7.2% discount rate (WACC) and 2.5% terminal growth. Every assumption is listed on this page with its source.
What growth is priced into Omega Healthcare Investors stock?
Today's price implies revenue growth of 14.6% a year for 5 years; our model assumes 5.1% a year on average over the same horizon. This is a reverse DCF: it holds our cash-flow model's other inputs and solves for the revenue growth that makes the model equal today's price of $44.90. A model estimate, not investment advice.
Omega Healthcare Investors (OHI) insider trading
The most recent insider filing (SEC Form 4) for Omega Healthcare Investors, Inc. (OHI): Golem Lucas M., CHIEF ACCOUNTING OFFICER, grant / award on 2026-10-01. The latest filings are listed on this page. A disclosure, not a signal to trade.
Stocks below our fair value instead
Not investment advice. TickerWorth Score is a model output.
Educational tool. Every output reflects the assumptions shown — not a prediction and not investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public filings and market data that can be wrong.